Marshall Wace
AMED

Marshall Wace’s Amedisys AMED Stock Holding History

Marshall Wace’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-186,111
Closed -$18.3M – 2857
2025
Q2 		$18.3M Sell
186,111
-4,907
-3% -$464K 0.02% 619
2025
Q1 		$17.7M Sell
191,018
-3,585
-2% -$331K 0.02% 548
2024
Q4 		$17.7M Sell
194,603
-147,343
-43% -$13.5M 0.02% 587
2024
Q3 		$33M Buy
341,946
+73,824
+28% +$7.2M 0.04% 372
2024
Q2 		$24.6M Sell
268,122
-23,381
-8% -$2.17M 0.03% 438
2024
Q1 		$26.9M Sell
291,503
-115,125
-28% -$10.8M 0.04% 417
2023
Q4 		$38.7M Buy
406,628
+92,485
+29% +$8.64M 0.07% 295
2023
Q3 		$29.3M Buy
314,143
+219,852
+233% +$20.3M 0.06% 330
2023
Q2 		$8.62M Buy
94,291
+2,994
+3% +$246K 0.02% 801
2023
Q1 		$6.71M Buy
+91,297
New +$7.9M 0.01% 861
2021
Q4 		– Sell
-12,477
Closed -$1.86M – 3830
2021
Q3 		$1.86M Buy
+12,477
New +$2.59M 0.01% 1613
2021
Q2 		– Sell
-3,469
Closed -$919K – 2615
2021
Q1 		$919K Sell
3,469
-11,656
-77% -$3.29M ﹤0.01% 1702
2020
Q4 		$4.44M Sell
15,125
-3,345
-18% -$858K 0.02% 614
2020
Q3 		$4.37M Sell
18,470
-7,542
-29% -$1.71M 0.03% 559
2020
Q2 		$5.17M Buy
+26,012
New +$4.85M 0.04% 457
2020
Q1 		– Sell
-32,963
Closed -$5.5M – 1603
2019
Q4 		$5.5M Sell
32,963
-49,482
-60% -$7.36M 0.04% 498
2019
Q3 		$10.8M Sell
82,445
-161,263
-66% -$21M 0.08% 272
2019
Q2 		$29.6M Buy
243,708
+23,205
+11% +$2.75M 0.24% 83
2019
Q1 		$27.2M Buy
220,503
+163,842
+289% +$20.6M 0.26% 75
2018
Q4 		$6.64M Buy
+56,661
New +$6.68M 0.07% 368
2017
Q1 		– Sell
-202,091
Closed -$8.62M – 318
2016
Q4 		$8.62M Sell
202,091
-227,058
-53% -$9.65M 0.06% 366
2016
Q3 		$20.4M Buy
429,149
+203,927
+91% +$10.2M 0.14% 171
2016
Q2 		$11.4M Buy
225,222
+123,938
+122% +$6.26M 0.1% 229
2016
Q1 		$4.9M Buy
+101,284
New +$3.91M 0.05% 347

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Marshall Wace's AMED Position: Q3 2025 in Review

Marshall Wace sold out of Amedisys (AMED) in Q3 2025, closing a stake of 186,111 shares — an estimated $18.3M sold.

Marshall Wace first reported a position in AMED in Q1 2016 and held it in 24 quarters. The position peaked at $38.7M in Q4 2023. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Marshall Wace reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Marshall Wace sold 186,111 Amedisys shares in Q3 2025, an estimated $18.3M.
  • Marshall Wace first reported a position in Amedisys in Q1 2016 and held it in 24 quarters.
  • Marshall Wace's Amedisys position peaked at $38.7M in Q4 2023.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Marshall Wace's 13F filing for Q3 2025, filed 13 Nov 2025.